GB790521A - Improvements in or relating to antibiotics - Google Patents

Improvements in or relating to antibiotics

Info

Publication number
GB790521A
GB790521A GB32684/55A GB3268455A GB790521A GB 790521 A GB790521 A GB 790521A GB 32684/55 A GB32684/55 A GB 32684/55A GB 3268455 A GB3268455 A GB 3268455A GB 790521 A GB790521 A GB 790521A
Authority
GB
United Kingdom
Prior art keywords
thiactin
per cent
chloroform
broad band
shoulder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB32684/55A
Inventor
Bernard Heinemann
Irving R Hooper
Martin John Cron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Laboratories Inc
Original Assignee
Bristol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Laboratories Inc filed Critical Bristol Laboratories Inc
Priority to GB32684/55A priority Critical patent/GB790521A/en
Publication of GB790521A publication Critical patent/GB790521A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

<PICT:0790521/IV (b)/1> A new antibiotic Thiactin is produced by cultivating a thiactin-producing strain of Streptomyces hawaiiensis especially S. hawaiiensis ATCC 12236 in an aqueous nutrient medium containing a source of carbohydrate, nitrogen, growth substances and mineral salts under submerged aerobic conditions at a temperature of 24 DEG to 30 DEG C. for 3 to 5 days. The initial pH of the medium is 6.0 to 6.2. Specified carbon sources are starch, sucrose, glucose, maltose, dextrose, glycerol, galactose, xylose, arabinose, rhamnose, fructose, lactose, insulin and dextrin. Specified nitrogen sources are amino acids, casein, fish meal, soybean meal, meat extracts, liver cake, urea, nitrates, ammonium compounds, distillers' grain slop, corn steep liquor, wheat steep liquor, whey, acid hydrolysed corn (or wheat) gluten, peptone, brewers' yeast, cottonseed meal, lactalbumin tryptone and offals Specified mineral salts are sodium chloride, potassium phosphate, magnesium sulphate, sodium nitrate and trace metals. A buffer such as calcium carbonate may be present. Thiactin is recovered from the clarified broth by solvent extraction and adsorption. The extraction is by means of a water-immiscible organic solvent such as butanol, chloroform or methyl isobutyl ketone. The extract is concentrated and the thiactin recovered by the addition of an alkane or by lyophilization. The crude thiactin is dissolved in a solvent used as chloroform and adsorbed on a chromatographic adsorbent such as alumina, charcoal or silica, followed by elution with e.g. methanol in chloroform. Salts of thiactin with mineral acids such as hydrochloric, phosphoric and sulphuric or organic acids such as hydrochloric, phosphoric and sulphuric or organic acids such as citric, tartaric and gluconic are prepared by adding the desired acid to an aqueous solution of thiactin. Alkali metal salts of thiactin are prepared by treating an aqueous suspension of the antibiotic with an alkali metal hydroxide. Thiactin is soluble in formamide, chloroform, 2-methoxy ethanol, butanol, dioxane, amyl alcohol; less soluble in acetone, benzene, ethyl acetate, dimethoxyethane, dimethoxy diethylene glycol and ethanol. Melts at 226-235 DEG C. Contains only the elements carbon, hydrogen, oxygen, nitrogen and sulphur and has a typical analysis of N = 15.3 to 18.1 per cent, C = 51.7 to 52.2 per cent, H = 5.56 to 5.66 per cent and S = 9.2 to 10.1 per cent. It exhibits characteristic adsorption bands in infra-red region of the spectrum when pelleted in potassium bromide at the following wavelengths expressed in microns: 2.98, 3.37; 4.20-4.28 (broad band); 6.05; 6.50-6.70 (broad band); 7.00-7.10 (shoulder) 7.25; 7.70-7.95 (broad band); 8.28; 8.85-8.98 (broad band); 9.17; 9.25-9.50 (shoulder); 9.65-9.85 (shoulder); 10.15-10.35 (broad band); 10.75; 11.23 and 12.40-12.60 (shoulder); specific rotation in chloroform of [a ]27D = - 69. On acid hydrolysis yields a mixture of amino acids comprising a -alanine, threonine, glycine, leucine and cysteine or cystine. The Rf value in (a) water is 1,2; (b) 10 per cent aqueous sodium citrate is 1; (c) butanol saturated with water is 8, 9 and 10; (d) dry methyl isobutyl ketone is 1-4; (e) butanol saturated with water containing 2 per cent p. toluene sulphonic acid is 10. Rf values in other solvent systems are also given. Thiactin is active against gram positive bacteria and mycobacteria. It is incorporated in therapeutic compositions (see Group VI).ALSO:The antibiotic thiactin (see Group IV (b)) is employed in non-toxic amounts in therapeutic compositions in admixture with a compatible carrier or diluent.
GB32684/55A 1955-11-15 1955-11-15 Improvements in or relating to antibiotics Expired GB790521A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB32684/55A GB790521A (en) 1955-11-15 1955-11-15 Improvements in or relating to antibiotics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB32684/55A GB790521A (en) 1955-11-15 1955-11-15 Improvements in or relating to antibiotics

Publications (1)

Publication Number Publication Date
GB790521A true GB790521A (en) 1958-02-12

Family

ID=10342452

Family Applications (1)

Application Number Title Priority Date Filing Date
GB32684/55A Expired GB790521A (en) 1955-11-15 1955-11-15 Improvements in or relating to antibiotics

Country Status (1)

Country Link
GB (1) GB790521A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1255548A1 (en) * 2000-01-31 2002-11-13 Eisai Co., Ltd. Use of thiostrepton as an anti-mycobacterial agent
US10117927B2 (en) 2015-04-28 2018-11-06 Daewoong Co., Ltd. Medium composition for preparing botulinum toxin

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1255548A1 (en) * 2000-01-31 2002-11-13 Eisai Co., Ltd. Use of thiostrepton as an anti-mycobacterial agent
EP1255548A4 (en) * 2000-01-31 2004-10-06 Eisai Co Ltd Use of thiostrepton as an anti-mycobacterial agent
US10117927B2 (en) 2015-04-28 2018-11-06 Daewoong Co., Ltd. Medium composition for preparing botulinum toxin
AU2016253789B2 (en) * 2015-04-28 2018-12-06 Daewoong Co., Ltd. Medium composition for preparing botulinum toxin

Similar Documents

Publication Publication Date Title
GB1083662A (en) A novel antibiotic, methods for its production and therapeutic compositions containing it
Kobayashi et al. Isolation and inhibitory activity of gabaculine, a new potent inhibitor of γ-aminobutyrate aminotransferase produced by a Streptomyces
GB2179042A (en) Ginsenoside-Rd
GB715362A (en) Improvements in or relating to antimicrobial agent
Nakamura et al. A New Antibiotic, Amidinomycin [N-(2’-Amidinoethyl)-3-Aminocyclopentanecarboxamide] Produced by a Streptomyces
GB790521A (en) Improvements in or relating to antibiotics
GB1355734A (en) Process for producing antibiotic material
US2797187A (en) Production of puromycin
GB764198A (en) The antibiotic vengicide and processes for the preparation of the antibiotics oxytetracycline and vengicide
GB793797A (en) Improvements in or relating to antibiotics
GB770065A (en) Production of tetracycline by fermentation
US4353986A (en) Process for producing antibiotic nanaomycin E
GB768364A (en) A new antibiotic anisomycin
US3974035A (en) Process for preparing a cephamycin type antibiotic substance
GB736325A (en) Antibiotic and its production
GB815381A (en) Antibiotic designated nucleocidin and preparation thereof
US3683074A (en) Antibiotic selenomycin
US3655877A (en) Plurallin and production thereof
GB684417A (en) A new antibiotic and a process for the production thereof
GB830874A (en) A new antibiotic mitomycin c and its production by fermentation
GB897581A (en) Preparation of a new antibiotic aspartocin
GB817385A (en) Process for the production of an antibiotic designated kanamycin
GB817729A (en) A new antibiotic p.a. 371
GB757089A (en) Improvements in or relating to antibiotics
GB872261A (en) New antibiotic rufochromomycine and process for its preparation